Werewolf Therapeutics is a biopharmaceutical company developing conditionally activated immunotherapies for cancer and immune-mediated conditions using its proprietary PREDATOR platform. Key products include WTX-124 (IL-2 INDUKINE) and WTX-330 (IL-12 INDUKINE) in clinical trials for solid tumors, plus preclinical INDUCER T cell engager molecules (WTX-1011, WTX-2022). In February 2026, the company adopted a restructuring plan and initiated a strategic alternatives review process.
expected 2026-11-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001785530-26-000006 | EDGAR | 117K words |
| 2025-03-11 | 2024-12-31 | 0001785530-25-000008 | EDGAR | 107K words |
| 2024-03-07 | 2023-12-31 | 0001785530-24-000012 | EDGAR | 102K words |
| 2023-03-23 | 2022-12-31 | 0001785530-23-000009 | EDGAR | — |
| 2022-03-24 | 2021-12-31 | 0001785530-22-000014 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-07-31 | 2026-06-30 | 0001785530-26-000019 | EDGAR | 70K words |
| 2025-11-04 | 2025-09-30 | 0001785530-25-000031 | EDGAR | 71K words |
| 2025-08-14 | 2025-06-30 | 0001785530-25-000021 | EDGAR | 70K words |
| 2025-05-08 | 2025-03-31 | 0001785530-25-000014 | EDGAR | 67K words |
| 2024-11-07 | 2024-09-30 | 0001785530-24-000034 | EDGAR | 66K words |
| 2024-08-08 | 2024-06-30 | 0001785530-24-000028 | EDGAR | 66K words |
| 2024-05-03 | 2024-03-31 | 0001785530-24-000020 | EDGAR | 65K words |
| 2023-11-14 | 2023-09-30 | 0001785530-23-000033 | EDGAR | 67K words |
| 2023-08-10 | 2023-06-30 | 0001785530-23-000025 | EDGAR | 66K words |
| 2023-05-11 | 2023-03-31 | 0001785530-23-000017 | EDGAR | 64K words |
| 2022-11-10 | 2022-09-30 | 0001785530-22-000038 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001785530-22-000031 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-21 | 0001193125-26-360059 | EDGAR | 3K words |
| 2026-08-20 | 0001193125-26-359185 | EDGAR | 1K words |
| 2026-07-31 | 0001785530-26-000018 | EDGAR | 2K words |
| 2026-03-27 | 0001785530-26-000005 | EDGAR | 2K words |
| 2026-02-24 | 0001193125-26-067569 | EDGAR | 1K words |
| 2026-02-13 | 0001193125-26-051455 | EDGAR | 2K words |
| 2026-02-06 | 0001193125-26-041305 | EDGAR | 1K words |
| 2025-12-18 | 0001193125-25-323787 | EDGAR | 5K words |
| 2025-11-04 | 0001785530-25-000030 | EDGAR | 2K words |
| 2025-10-06 | 0001193125-25-231953 | EDGAR | 1K words |
82 total filings indexed. 55 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001785530 |
| Ticker | HOWL |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.werewolftx.com |
| Listed | 2021-04-30 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HOWL (~200 tokens, structured JSON with cryptographic provenance)